Pricing Log in Create free account
Thursday 12 November 2026 Export INCY’s income statement to Excel — free account

Incyte Corporation

INCY

Healthcare Biotechnology

Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024.

Revenue
+14.0%
EPS
−277.9%
Free cash flow
−233.0%
Total debt
−10.5%

Quarter to September 2026, against a year earlier

121.89 0.38 −0.31%
Market cap
$24.9B
P/E
58.1×
Fwd P/E
57.3×
Dividend yield
—
F-score
9/9
ROIC
21.6%
Net debt / EBITDA
−2.2×
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Incyte Corporation (INCY) EV/EBITDA

Alert me on EV/EBITDA

As of 12 November 2026, Incyte Corporation (INCY) trades at a EV/EBITDA of 28.9×. Over the past ten years it has ranged from 0.0× (March 2021) to 99,927× (August 2017); the current reading is higher than 54% of that period. That is above the Biotechnology industry median of 0.7× and above the Healthcare sector median of 9.3×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 9.8× (87.91%)
FY2024 81.0× 416.49%
FY2023 15.7× (29.85%)
FY2022 22.3× 3.65%
FY2021 21.6× —
FY2020 0.0× —
FY2019 36.6× (44.28%)
FY2018 65.6× —
FY2017 0.0× —
FY2016 93.7× (53.82%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 28.8× 196.23%
Jun 2026 9.7× 11.97%
Mar 2026 8.7× (11.43%)
Dec 2025 9.8× 12.30%
43 more quarters

Against its own ten years

Low 0.0× High 99,927×
Ten-year median 22.5×
Current reading's percentile 54

EV/EBITDA against peers

Company EV/EBITDA
ROIV Roivant Sciences Ltd. compare n/m
INSM Insmed, Inc. compare n/m
BNTX BioNTech SE Sponsored ADR compare n/m
EXEL Exelixis, Inc. compare 15.9×
JAZZ Jazz Pharmaceuticals PLC compare 16.1×
ALNY Alnylam Pharmaceuticals, Inc. compare 17.9×
INCY Incyte Corporation 28.9×
GMAB Genmab A/S Sponsored ADR compare 30.4×
ASND Ascendis Pharma A/S compare 52.3×
Biotechnology industry median 0.7×
Healthcare sector median 9.3×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on INCY